Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FZ9H1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,761
Award facts
- Contract value 100% obligated
- $3,760.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order on June 2, 2025, by the Defense Logistics Agency to supply ACTEMRA 162 mg/0.9 mL syringes valued at $3,760.51 with a completion date of June 3, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
The SPE2DX contract serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to furnish a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. Under this framework, the company supplies critical medical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for ACTEMRA, a biologic immunosuppressant medication commonly used in rheumatologic and immunologic treatments, represents a discrete fulfillment transaction within AmerisourceBergen's larger role as a pharmaceutical prime vendor supporting Department of Defense medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FZ9H1?
SPE2DB25FZ9H1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FZ9H1 worth?
The government has obligated $3,761 on SPE2DB25FZ9H1.
Is contract SPE2DB25FZ9H1 an order under another contract?
Yes. SPE2DB25FZ9H1 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FZ9H1 competed?
The extent of competition for SPE2DB25FZ9H1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award